Bioalternatives is a private company (Contract Research Organization) specialized in cellular and molecular pharmacology. Bioalternatives provides services to support the early stages of drug discovery and the claim substantiation of healthcare compounds using up-to-date in vitro solutions. Bioalternatives develops and manages informative cell-based assays allowing faster and cost-effective selection of your compounds. Our capabilities include: - in vitro model development & characterization - development & management of cell-based assays - biological target identification - primary and secondary screening for hit to lead identification - profiling, mechanism of action studies; proof-of-concept evidencing - analysis of preclinical/clinical samples
Looking for a particular BIOalternatives employee's phone or email?
The BIOalternatives annual revenue was $3 million in 2026.
7 people are employed at BIOalternatives.
BIOalternatives is based in New York City, New York.
The NAICS codes for BIOalternatives are [5417, 541713, 541, 54, 54171].
The SIC codes for BIOalternatives are [873, 87].